Cellectis S.A.
HealthcareNASDAQ:CLLS · NASDAQ Global Market
+$0.00 today
Vol 0.04M · Avg 0.04M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+132.33%
Period High
$5.35
Period Low
$1.33
Latest
$3.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$889.71M
Alto Neuroscience, Inc.
NYSE:ANRO
$753.47M
DBV Technologies S.A.
NASDAQ:DBVT
$416.60M
Silence Therapeutics plc
NASDAQ:SLN
$316.00M
Amarin Corporation plc
NASDAQ:AMRN
$315.21M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
AC Immune S.A.
NASDAQ:ACIU
$235.10M
Korro Bio, Inc.
NASDAQ:KRRO
$115.56M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$106.17M
Mereo BioPharma Group plc
MREO
$48.68M
What is the latest CLLS filing?
The latest filing shown is 6-K dated Jun 11, 2026.
How many recent filings does CLLS have?
Intrinsic Alpha currently shows 20 recent filings for CLLS.
Explore More
Continue the stock analysis
Jump to another research area for this company.